Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H12O7S2 |
| Molecular Weight | 344.36 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(O)C(=C2)S(O)(=O)=O
InChI
InChIKey=SVXZTCUBEFUKRQ-UHFFFAOYSA-N
InChI=1S/C13H12O7S2/c1-9-2-5-11(6-3-9)22(18,19)20-10-4-7-12(14)13(8-10)21(15,16)17/h2-8,14H,1H3,(H,15,16,17)
| Molecular Formula | C13H12O7S2 |
| Molecular Weight | 344.36 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Sultosilic acid is a benzenesulfonate ester. Sultosilic acid has been shown to be a hypolipidaemic drug both in animal experiments and in human clinical studies, chemically unrelated to other such drugs. The compound is being developed as a human drug (Mimedran ®) and is formulated as the piperazine salt (A-585). The recommended daily dose is three times one tablet containing 500 mg of Sultosilic acid.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:53 GMT 2025
by
admin
on
Mon Mar 31 18:10:53 GMT 2025
|
| Record UNII |
62734PD6SM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
62734PD6SM
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
57775-26-5
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
C72085
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
C024325
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
m10394
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000082959
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
260-943-0
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
DTXSID50206459
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
SUB10764MIG
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
68775
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
2542
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105492
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY | |||
|
4034
Created by
admin on Mon Mar 31 18:10:53 GMT 2025 , Edited by admin on Mon Mar 31 18:10:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
